Venture Capital

A Nasdaq exec's visit to Seoul's Galaxy Corp. reveals a global strategy fueled by celebrity IP, AI robots, and a key partnership with Star Legend.

As it nears its 10th anniversary, Prelude Solutions earns dual honors from the Philadelphia Business Journal for a unique model that bakes giving into its revenue.

A Hong Kong professor's tech, inspired by desert ants, is cooling cities globally without electricity, slashing energy use and carbon emissions.

Over 110 exchanges unite for women's rights, but the real push is for measurable change in corporate transparency, leadership, and investment strategy.

Fueled by strong investor demand and a lead order from Purpose Global Resource Fund, Lithium Africa will acquire a key South African lithium asset.

Thinkific reports strong 2025 revenue and a return to profitability, betting its future on enterprise clients and its new 'Thinker' AI platform.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

For the third year, Brightline is a top startup employer. We explore how its unique model of growth and compassion is changing pediatric mental healthcare.

Palo Alto Networks founder argues AI won't kill cybersecurity, citing data costs and compliance as major roadblocks for today's AI security solutions.

Zelestra begins construction on two huge solar farms in Texas, backed by Meta, promising hundreds of jobs and a major boost to the state's green grid.

With a severe doctor shortage, one company just raised millions to prove nurse practitioners are the future of primary care for America's seniors.

Top exec search firm Christian & Timbers moves from placing leaders to deploying AI, launching a new arm to deliver measurable ROI with Agentic systems.

A new partnership is pioneering a data-driven family engagement platform, setting a new standard for pediatric health and digital transformation.

At MWC26, iFLYTEK launched ambitious AI translation glasses, but faces stiff competition from Google and Alibaba, along with lingering privacy questions.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

Asia's top tech expo unveils its 2026 theme, focusing on AI's leap from code to robotics, wearables, and smart systems, cementing the region's global role.

Starton Therapeutics files patents to combine its continuous low-dose therapy, STAR-LLD, with CAR-T, aiming to enhance cancer-killing power and durability.

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.